Infezioni di derivazioni ventricolari e profilassi antibiotica

Translated title of the contribution: Antimicrobial prophylaxis for CSF shunt infections

P. Marone, E. Carretto, F. Tartara, C. Segu, M. Rondanelli

Research output: Contribution to journalArticle

Abstract

Although several studies have attempted to determine the usefulness of antibiotic prophylaxis in patients undergoing CSF shunt surgery, it is impossible to define exactly its effect on the incidence of infections. Many trials are unsuitable for statistical analysis and the true incidence of different bacterial strains varies from unit to unit. We evaluated 52 cases of CSF shunt infections that occurred in our neurosurgical department in the last five years. On the basis of the strains isolated, we propose an antimicrobial prophylaxis for CSF shunt surgery based on administration of vancomycin 20 mg and amikacin 10 mg in a single dose, instilled directly in the IVT shunt at the time of surgical procedure. We evaluated the rate of infections, the kinetics of the two antibiotics and the incidence of ototoxicity or other neurologic sequelae in nine CSF shunt-surgery patients. We found that the use of vancomycin and amikacin through intraventricular injection is safe and provides 1-20 times the minimum inhibitory concentration for staphylococci.

Original languageItalian
Pages (from-to)67-70
Number of pages4
JournalMicrobiologia Medica
Volume12
Issue number2
Publication statusPublished - 1997

Fingerprint

Amikacin
Vancomycin
Incidence
Infection
Intraventricular Injections
Antibiotic Prophylaxis
Microbial Sensitivity Tests
Staphylococcus
Nervous System
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Infezioni di derivazioni ventricolari e profilassi antibiotica. / Marone, P.; Carretto, E.; Tartara, F.; Segu, C.; Rondanelli, M.

In: Microbiologia Medica, Vol. 12, No. 2, 1997, p. 67-70.

Research output: Contribution to journalArticle

Marone, P, Carretto, E, Tartara, F, Segu, C & Rondanelli, M 1997, 'Infezioni di derivazioni ventricolari e profilassi antibiotica', Microbiologia Medica, vol. 12, no. 2, pp. 67-70.
Marone, P. ; Carretto, E. ; Tartara, F. ; Segu, C. ; Rondanelli, M. / Infezioni di derivazioni ventricolari e profilassi antibiotica. In: Microbiologia Medica. 1997 ; Vol. 12, No. 2. pp. 67-70.
@article{a730d74f78b044f6a0580040384be660,
title = "Infezioni di derivazioni ventricolari e profilassi antibiotica",
abstract = "Although several studies have attempted to determine the usefulness of antibiotic prophylaxis in patients undergoing CSF shunt surgery, it is impossible to define exactly its effect on the incidence of infections. Many trials are unsuitable for statistical analysis and the true incidence of different bacterial strains varies from unit to unit. We evaluated 52 cases of CSF shunt infections that occurred in our neurosurgical department in the last five years. On the basis of the strains isolated, we propose an antimicrobial prophylaxis for CSF shunt surgery based on administration of vancomycin 20 mg and amikacin 10 mg in a single dose, instilled directly in the IVT shunt at the time of surgical procedure. We evaluated the rate of infections, the kinetics of the two antibiotics and the incidence of ototoxicity or other neurologic sequelae in nine CSF shunt-surgery patients. We found that the use of vancomycin and amikacin through intraventricular injection is safe and provides 1-20 times the minimum inhibitory concentration for staphylococci.",
keywords = "Amikacin, Antimicrobial prophylaxis, CSF shunt infection, Vancomycin",
author = "P. Marone and E. Carretto and F. Tartara and C. Segu and M. Rondanelli",
year = "1997",
language = "Italian",
volume = "12",
pages = "67--70",
journal = "Microbiologia Medica",
issn = "1120-0146",
publisher = "Associazione Microbiologici Clinici Italiani",
number = "2",

}

TY - JOUR

T1 - Infezioni di derivazioni ventricolari e profilassi antibiotica

AU - Marone, P.

AU - Carretto, E.

AU - Tartara, F.

AU - Segu, C.

AU - Rondanelli, M.

PY - 1997

Y1 - 1997

N2 - Although several studies have attempted to determine the usefulness of antibiotic prophylaxis in patients undergoing CSF shunt surgery, it is impossible to define exactly its effect on the incidence of infections. Many trials are unsuitable for statistical analysis and the true incidence of different bacterial strains varies from unit to unit. We evaluated 52 cases of CSF shunt infections that occurred in our neurosurgical department in the last five years. On the basis of the strains isolated, we propose an antimicrobial prophylaxis for CSF shunt surgery based on administration of vancomycin 20 mg and amikacin 10 mg in a single dose, instilled directly in the IVT shunt at the time of surgical procedure. We evaluated the rate of infections, the kinetics of the two antibiotics and the incidence of ototoxicity or other neurologic sequelae in nine CSF shunt-surgery patients. We found that the use of vancomycin and amikacin through intraventricular injection is safe and provides 1-20 times the minimum inhibitory concentration for staphylococci.

AB - Although several studies have attempted to determine the usefulness of antibiotic prophylaxis in patients undergoing CSF shunt surgery, it is impossible to define exactly its effect on the incidence of infections. Many trials are unsuitable for statistical analysis and the true incidence of different bacterial strains varies from unit to unit. We evaluated 52 cases of CSF shunt infections that occurred in our neurosurgical department in the last five years. On the basis of the strains isolated, we propose an antimicrobial prophylaxis for CSF shunt surgery based on administration of vancomycin 20 mg and amikacin 10 mg in a single dose, instilled directly in the IVT shunt at the time of surgical procedure. We evaluated the rate of infections, the kinetics of the two antibiotics and the incidence of ototoxicity or other neurologic sequelae in nine CSF shunt-surgery patients. We found that the use of vancomycin and amikacin through intraventricular injection is safe and provides 1-20 times the minimum inhibitory concentration for staphylococci.

KW - Amikacin

KW - Antimicrobial prophylaxis

KW - CSF shunt infection

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=0031397915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031397915&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0031397915

VL - 12

SP - 67

EP - 70

JO - Microbiologia Medica

JF - Microbiologia Medica

SN - 1120-0146

IS - 2

ER -